One of the novelties of the present work is the analysis of the expression of serotonin hepatic (HTR2A, HTR2B, and HTR3) and jejunal receptors (HTR3 and HTR4) in a cohort of women with MO and NAFLD. Here, HTR2A is linked to metabolic dysfunction-associated steatotic liver disease.